Pharmaceuticals

Candesartan Cilexetil Drug Market Developments and Growth Prospects Through 2026–2030

March 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Candesartan Cilexetil Drug Market Evolve From 2026 To 2030?

The candesartan cilexetil drug market has experienced robust expansion recently. This market is projected to expand from $1.65 billion in 2025 to $1.74 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 5.4%. Historically, this growth has stemmed from factors such as a rise in hypertension prevalence, the clinical effectiveness of ARBs, a move away from ACE inhibitors, broader cardiovascular treatment guidelines, and an expanding elderly demographic.

The candesartan cilexetil drug market size is projected to experience significant expansion in the upcoming years, with expectations to reach $2.15 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.5%. This anticipated growth during the forecast period is attributable to factors such as the increasing prevalence of chronic cardiovascular diseases, the expanding adoption of generic drugs, the rising integration of combination therapies, improved healthcare access in developing regions, and a growing focus on preventive cardiovascular care. Major developments expected in the forecast period include a rise in the use of angiotensin receptor blockers for hypertension, increased prescribing for heart failure management, an escalating demand for generic antihypertensive medications, the diversification of combination therapy formulations, and enhanced patient compliance due to once-daily dosing.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24183&type=smp

What Major Drivers Are Influencing Demand In The Candesartan Cilexetil Drug Market?

The increasing occurrence of high blood pressure is anticipated to drive expansion in the candesartan cilexetil drug market. Hypertension, or elevated blood pressure, is a medical condition characterized by persistently excessive blood force against arterial walls, generally diagnosed at 130/80 mmHg or above. This widespread condition is linked to escalating unhealthy lifestyle choices, including inadequate nutrition, insufficient exercise, and significant stress. Candesartan cilexetil aids in controlling hypertension by inhibiting angiotensin II, a hormone that narrows blood vessels, thereby causing blood vessels to relax and lowering blood pressure. For example, data from the Centers for Disease Control and Prevention, a US government agency, indicated in October 2024 that between August 2021 and August 2023, the incidence of hypertension increased notably: by 124.48% when moving from the 18–39 age bracket to the 40–59 age bracket, and by 36.38% from the 40–59 age bracket to those 60 and above. Consequently, the expanding challenge of hypertension is boosting the demand for the candesartan cilexetil drug market.

Which Segment Areas Are Covered In The Candesartan Cilexetil Drug Market Analysis?

The candesartan cilexetil drug market covered in this report is segmented –

1) By Product Type: Tablets, Capsules, Other Product Types

2) By Indication: Hypertension, Heart Failure, Diabetic Nephropathy, Left Ventricular Hypertrophy

3) By Dosage Strength: 4 MG, 8 MG, 16 MG, 32 MG

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Healthcare Facilities

5) By Application: Adult, Children And Adolescent

Subsegments:

1) By Tablets: Immediate-Release Tablets, Extended-Release Tablets, Dispersible Tablets, Chewable Tablets

2) By Capsules: Hard Gelatin Capsules, Soft Gelatin Capsules, Modified-Release Capsules

3) By Other Product Types: Oral Suspensions, Injectable Formulations, Combination Drug Formulations

What Key Developments And Trends Are Impacting The Candesartan Cilexetil Drug Market?

Leading companies within the candesartan cilexetil drug market are concentrating on developing innovative formulations, including treatments for hypertension, combination therapies with other antihypertensive drugs, and extended-release versions, all designed to improve patient adherence and enhance therapeutic outcomes. Treating hypertension involves employing medications, lifestyle modifications, and various interventions aimed at reducing and managing elevated blood pressure to lessen the risk of complications like heart disease, stroke, and kidney damage. For example, in March 2025, Scienture Inc., a US-based pharmaceutical company, obtained approval from the US Food & Drug Administration (USFDA) for its New Drug Application (NDA) for SCN-102, released as Arbli, a losartan potassium oral suspension (10 mg/mL). This angiotensin II receptor blocker (ARB) formulation offers a beneficial alternative for patients, particularly in pediatric and geriatric populations, who face challenges swallowing tablets. The introduction of this product demonstrates the increasing interest in alternative dosage forms across the antihypertensive market and signals a progression towards more personalized, patient-friendly drug delivery systems.

Which Global Companies Are Actively Competing In The Candesartan Cilexetil Drug Market?

Major companies operating in the candesartan cilexetil drug market are Merck & Co. Inc., Bayer AG, Novartis AG, AstraZeneca plc, GSK plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Sandoz Group AG, Viatris Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Limited, Cipla Limited, Zydus Lifesciences Ltd., Hetero Drugs Limited, Torrent Pharmaceuticals Limited, Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Limited, Oubari Pharmaceutical Co.

Read the full candesartan cilexetil drug market report here:

https://www.thebusinessresearchcompany.com/report/candesartan-cilexetil-drug-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Candesartan Cilexetil Drug Market?

North America was the largest region in the candesartan cilexetil drug market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the candesartan cilexetil drug market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Candesartan Cilexetil Drug Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24183&type=smp

Browse Through More Reports Similar to the Global Candesartan Cilexetil Drug Market 2026, By The Business Research Company

Cannabidiol Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabidiol-global-market-report

Benzodiazepine Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/benzodiazepine-drugs-global-market-report

Cytotoxic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/cytotoxic-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795